Interdisciplinary Program in Neuroscience, Aysel Sabuncu Brain Research Center, Bilkent University, Ankara, Turkey.
National Nanotechnology Research Center and Institute of Materials Science and Nanotechnology (UNAM), Bilkent University, Ankara, Turkey.
Gerontology. 2023;69(12):1424-1436. doi: 10.1159/000534343. Epub 2023 Oct 4.
Interventions targeting cholinergic neurotransmission like acetylcholinesterase (AChE) inhibition distinguish potential mechanisms to delay age-related impairments and attenuate deficits related to neurodegenerative diseases. However, the chronic effects of these interventions are not well described.
In the current study, global levels of cholinergic, cellular, synaptic, and inflammation-mediating proteins were assessed within the context of aging and chronic reduction of AChE activity. Long-term depletion of AChE activity was induced by using a mutant zebrafish line, and they were compared with the wildtype group at young and old ages.
Results demonstrated that AChE activity was lower in both young and old mutants, and this decrease coincided with a reduction in ACh content. Additionally, an overall age-related reduction in AChE activity and the AChE/ACh ratio was observed, and this decline was more prominent in wildtype groups. The levels of an immature neuronal marker were upregulated in mutants, while a glial marker showed an overall reduction. Mutants had preserved levels of inhibitory and presynaptic elements with aging, whereas glutamate receptor subunit levels declined.
Long-term AChE activity depletion induces synaptic and cellular alterations. These data provide further insights into molecular targets and adaptive responses following the long-term reduction of AChE activity that was also targeted pharmacologically to treat neurodegenerative diseases in human subjects.
针对胆碱能神经递质的干预,如乙酰胆碱酯酶(AChE)抑制,区分了潜在的机制,可以延缓与年龄相关的损伤,并减轻与神经退行性疾病相关的缺陷。然而,这些干预措施的慢性效应还没有很好地描述。
在目前的研究中,在衰老和慢性 AChE 活性降低的背景下,评估了胆碱能、细胞、突触和炎症调节蛋白的整体水平。通过使用突变型斑马鱼系来诱导 AChE 活性的长期耗竭,并将其与年轻和年老的野生型组进行比较。
结果表明,年轻和年老的突变体中的 AChE 活性均较低,这种减少与 ACh 含量的减少相吻合。此外,还观察到与年龄相关的 AChE 活性和 AChE/ACh 比值整体下降,野生型组的下降更为明显。突变体中的不成熟神经元标志物上调,而神经胶质标志物总体减少。突变体在衰老时保持抑制性和突触前元素的水平,而谷氨酸受体亚基水平下降。
长期 AChE 活性耗竭会引起突触和细胞的改变。这些数据为长期 AChE 活性降低后的分子靶点和适应反应提供了进一步的见解,这种降低也被靶向药理学用于治疗人类神经退行性疾病。